KRIS TON: Open Payments
NPI 1205860988 · FOUNTAIN VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 17 payments from 12 companies in 2025. Trend: 2023 $18 · 2024 $117 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $68 |
| Daiichi Sankyo Inc. | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| PUMA BIOTECHNOLOGY, INC. | 2 | $47 |
| ABBVIE INC. | 2 | $46 |
| Genmab U.S., Inc. | 1 | $33 |
| Exelixis Inc. | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $31 |
| Karyopharm Therapeutics Inc. | 1 | $28 |
| Aveo Pharmaceuticals, Inc. | 1 | $27 |
Products named: IMFINZI, NERLYNX, FRUZAQLA, Epkinly, CABOMETYX, Nubeqa, DATROWAY, XPOVIO.
Industry payments across CA — which companies pay providers there.
